January 2017 FDA Recall Carbidopa And Levodopa by Sun Pharmaceutical Industries, Inc.
D-0455-2017 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries, Inc. on January 12, 2017 for the product Carbidopa And Levodopa. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0455-2017

Reason for Recall
Failed Dissolution Specifications
Initiated
01-12-2017
Reported
02-08-2017
Quantity
8,537 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Sun Pharmaceutical Industries, Inc.
Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b) 500-count bottles (NDC 62756-519-13) Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd. Halol-Baroda Highway, Halol-389 350 Gujarat, India.

Batch or Lot Expiration Information

Lot# a) JKP5530A Exp. 12/17, JKP3991A Exp. 11/17, JKR6535A Exp. 07/18 b) JKP5529A Exp. 11/17